TABLE 4

Impact of PET on Intended Management During Chemotherapy Monitoring

Continue therapySwitch therapyAdjust therapyImageStop therapy
CancerTime periodPatients (n)n%n%n%n%n%
Bladder20061,08928326.031028.515614.3726.626824.6
20091,47963542.939927.0865.8674.529219.7
Kidney20061,07542039.125723.916815.6575.317316.1
20091,9341,01552.547824.71065.5924.824312.6
Pancreas20061,78372040.447826.827115.2814.523313.1
20092,1981,10350.255025.01516.9984.529613.5
Prostate20061,02434834.026125.514514.2696.720119.6
20091,33655241.340230.11047.8896.718914.1
Small cell lung20061,34841530.838928.920715.4604.527720.5
20092,0831,00948.450324.11014.8743.639619.0
Uterus200681824730.226031.810112.3485.916219.8
20091,11345540.931328.1716.4454.122820.5
All other cancer20062,10076036.253825.629013.81105.240219.1
20094,3872,04746.71,12125.62846.51984.573716.8
Total cases200610,2343,55434.72,73526.71,49214.65525.41,90118.6
200915,6117,31546.94,04925.99766.37224.62,54716.3